Quakenbr\u00fcck\/ Frank\u00adfurt a. M. \u2014 Gowling WLG advi\u00adses Axeleo Capi\u00adtal as lead inves\u00adtor in the \u20ac16 million Series A finan\u00adcing round for Bioweg. Bioweg is a German biotech based in Quaken\u00adbr\u00fcck that deve\u00adlops high-perfor\u00admance, biode\u00adgra\u00adda\u00adble ingre\u00addi\u00adents to replace inten\u00adtio\u00adnally added acrylic poly\u00admer-based microplastics. <\/p>\n
The company has closed a \u20ac16 million Series A finan\u00adcing round. The round was led by Axeleo Capi\u00adtal Green<\/strong> (from its indus\u00adtry fund), toge\u00adther with EIC Fund, NBank Capi\u00adtal, BonVen\u00adture<\/strong> and seed inves\u00adtor Dr.-Ing.<\/strong> <\/p>\n The capi\u00adtal will support the cons\u00adtruc\u00adtion of Biowe\u00adg\u2019s first bacte\u00adrial cellu\u00adlose plant in Germany and acce\u00adle\u00adrate market entry across Europe. The latest funding round, which brings the total amount raised by the company to date to \u20ac32.5 million, will enable the move from pilot to indus\u00adtrial produc\u00adtion, inclu\u00adding the cons\u00adtruc\u00adtion of an indus\u00adtrial bacte\u00adrial cellu\u00adlose plant in Germany desi\u00adgned to meet the growing demand from indus\u00adtrial custo\u00admers for sustainable, micro\u00adpla\u00ads\u00adtic-free ingredients. <\/p>\n Gowling WLG<\/strong> \u2018s German corpo\u00adrate and IP team advi\u00adsed Axeleo Capi\u00adtal on its invest\u00adment in Bioweg, a German biotech\u00adno\u00adlogy company. The team was led by Dr. Michael Lamsa, Part\u00adner and Co-Head of M&A, Private Equity and Venture Capi\u00adtal in Germany, and supported by Coun\u00adsel Micha Gers\u00addorf and Asso\u00adciate Phil\u00adipp Esmek (both Corporate\/M&A; Frank\u00adfurt) as well as Part\u00adner Miray Kavruk and Asso\u00adciate Ales\u00adsan\u00addra Birken\u00addorf (both IP\/IT; Frankfurt). <\/p>\n Axeleo Capi\u00adtal<\/strong> is a multi-stra\u00adtegy tech invest\u00adment manage\u00adment firm support\u00ading Euro\u00adpe\u2019s next leaders in digi\u00adtal and green trans\u00adfor\u00adma\u00adtion, provi\u00adding seed to Series B invest\u00adments combi\u00adned with stra\u00adte\u00adgic, hands-on support to bold backers in key industries.<\/p>\n Dr. Michael Lamsa<\/strong> said: \u201cWe are deligh\u00adted to have legally supported Axeleo Capi\u00adtal as lead inves\u00adtor in this land\u00admark finan\u00adcing round for Bioweg. Bioweg exem\u00adpli\u00adfies the next gene\u00adra\u00adtion of sustainable mate\u00adrial inno\u00adva\u00adtion. The invest\u00adment under\u00adlines not only the confi\u00addence in the foun\u00adding team, but also the strong inter\u00adna\u00adtio\u00adnal inte\u00adrest in scalable solu\u00adti\u00adons in the field of sustainable mate\u00adri\u00adals. The market for real alter\u00adna\u00adti\u00adves to micro\u00adpla\u00ads\u00adtics is ready and the company is extre\u00admely well posi\u00adtio\u00adned to make a real impact with its tech\u00adno\u00adlogy, both econo\u00admic\u00adally and environmentally.\u201d<\/p>\n Marc Lech\u00adantre, Part\u00adner at Axeleo Capi\u00adtal<\/strong>, commen\u00adted: \u201cWe are grateful for the strong support of Michael and the team at Gowling WLG, which was criti\u00adcal to this transaction.\u201d<\/p>\n Gowling WLG\u2019s corpo\u00adrate team provi\u00addes excel\u00adlent legal advice through a part\u00adner-led service of corpo\u00adrate lawy\u00aders whose clients range from leading global finan\u00adcial insti\u00adtu\u00adti\u00adons and listed compa\u00adnies to private compa\u00adnies and entre\u00adpre\u00adneurs. The 200-strong team has exten\u00adsive expe\u00adri\u00adence in all areas of corpo\u00adrate advice, inclu\u00adding AIM and main market equity capi\u00adtal markets, invest\u00adment funds, private equity and public and private mergers and acqui\u00adsi\u00adti\u00adons. \u2014https:\/\/gowlingwlg.com\/ <\/p>\n About Axeleo Capital <\/strong><\/p>\n Axeleo Capi\u00adtal is a multi-stra\u00adtegy tech\u00adno\u00adlogy inves\u00adtor back\u00ading Euro\u00adpe\u2019s next leaders in digi\u00adtal and green trans\u00adfor\u00adma\u00adtion. Alexeo provi\u00addes seed to series B invest\u00adments combi\u00adned with stra\u00adte\u00adgic, hands-on support for foun\u00adders in key indus\u00adtries. With \u20ac300 million in assets under manage\u00adment, 4 successful funds raised and 18 employees, we have made over 70 invest\u00adments across the EU in recent years and achie\u00adved 13 successful exits. <\/p>\n About Gowling WLG<\/b><\/p>\n Gowling WLG is an inter\u00adna\u00adtio\u00adnal law firm with more than 1,500 lawy\u00aders in 20 offices world\u00adwide. We advise clients of all sizes in Germany and abroad across all sectors and prac\u00adti\u00adces. We see the world through our clients\u2019 eyes. Quakenbr\u00fcck\/ Frank\u00adfurt a. M. \u2014 Gowling WLG advi\u00adses Axeleo Capi\u00adtal as lead inves\u00adtor in the \u20ac16 million Series A finan\u00adcing round for Bioweg. Bioweg is a German biotech based in Quaken\u00adbr\u00fcck that deve\u00adlops high-perfor\u00ad\u00admance, biode\u00adgra\u00adda\u00adble ingre\u00addi\u00adents to replace inten\u00adtio\u00adnally added acrylic poly\u00ad\u00admer-based micro\u00adpla\u00ads\u00adtics. The company has closed a \u20ac16 million Series A finan\u00adcing round. The [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":56856,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[1366],"tags":[],"class_list":["post-56857","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"\n
\nGowling WLG (UK) LLP is a member of Gowling WLG, an inter\u00adna\u00adtio\u00adnal law firm consis\u00adting of inde\u00adpen\u00addent and auto\u00adno\u00admous enti\u00adties provi\u00adding services world\u00adwide. \u2014 \u2014 www.gowlingwlg.com. <\/p>\n","protected":false},"excerpt":{"rendered":"